The above chart presents the market trend analysis for espee biopharma&fine chem llc from 2024 to 2025.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2025, the company has completed 713 transactions, with a transaction quantity of 17615.35 and a transaction weight of 0.92.
YearTransactionsQuantityWeight
Bill of lading data
<
1/15
>
Trade date
2025/05/31
B/L No.
2401468
Supplier
espee biopharma&fine chem llc
Buyers
azurity pharmaceuticals india llp
Product description
SERTRALINE HYDROCHLORIDE CAPSULE 150MG (30 IN 1 BTL) (R&D PURPOSE NOT FOR SALE)SERTRALINE HYDROCHLORIDE CAPSULE 150MG (30 IN 1 BTL) (R&D PU
Expand
Product description
SERTRALINE HYDROCHLORIDE CAPSULE 200MG (30 IN 1 BTL) (R&D PURPOSE NOT FOR SALE)SERTRALINE HYDROCHLORIDE CAPSULE 200MG (30 IN 1 BTL) (R&D PU
Expand
espee biopharma&fine chem llc is united states Supplier,
and primarily engages in the import and export business of products such as tablet,bottle,injection.
According to the 52wmb.com global trade database, as of 2025-10-15, the company has completed 4017 international trades,
with its main trading regions covering india,bangladesh,south africa etc.
The core products include HS30049099,HS30049049,HS90258090 etc,
often transported via chicago,port new york etc,
and its main trading partners are alembic pharmaceuticals ltd.,cipla ltd.,mankind pharma ltd..
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on espee biopharma&fine chem llc is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.